Results 61 to 70 of about 699,373 (191)

Toward Precision Medicine: Gene Therapy Applications in the Management of Uveal Melanoma

open access: yesCancer Reports, Volume 8, Issue 12, December 2025.
ABSTRACT Background Uveal melanoma (UM) is the prevailing malignant tumor that develops within the eye in adults, and it has a bleak outlook because of the few treatment choices available and the high likelihood of returning after treatment. Currently, surgical intervention, radiation therapy, and a combination of both modalities are available ...
Alireza Azani   +13 more
wiley   +1 more source

Stimuli‐responsive systems: A focus on controlled drug delivery for posterior segment ocular disease

open access: yesResponsive Materials, Volume 3, Issue 4, November 2025.
This review highlights recent advances in stimuli‐responsive drug delivery for posterior segment diseases, focusing on mechanisms and potential. It also explores mechanically interlocked molecules and bioorthogonal reactions as novel approaches. Challenges and future perspectives are discussed, aiming to bridge the gap between research and clinical ...
Chengzhi Zhang   +11 more
wiley   +1 more source

Subconjunctival injection of anti-VEGF agent bevacizumab as treatment in patients with dry eye disease

open access: yesPakistan Journal of Pharmaceutical Sciences
To assess the effect of subconjunctival injection of anti-VEGF bevacizumab in the management of dry eye disease in a tertiary care hospital. In this quasi-experimental trial 150 eyes of 75 patients were selected using non-probability consecutive sampling
Muhammad Kaunain Ghoghari   +5 more
doaj   +1 more source

Comparison of different doses of subconjunctival sunitinib with bevacizumab in the treatment of corneal neovascularization in experimental rats

open access: yesJournal of Research in Medical Sciences, 2017
Background: To compare the efficacy of subconjunctival administration of bevacizumab and different doses of sunitinib malate in reducing corneal neovascularization (CNV).
Mohammad Nasser Hashemian   +11 more
doaj   +1 more source

Conbercept Treatment for Heart‐Shaped Vascular Intertwined Nets in Macular Neovascularization: Anti‐VEGF Drug Therapy Strategy Based on Vascular Geometry Diagnosed by OCTA

open access: yesClinical Case Reports, Volume 13, Issue 10, October 2025.
A 63‐year‐old male with a history of hypertension and diabetes developed acute vision loss, which was attributed to macular neovascularization secondary to hypertensive retinopathy. Optical coherence tomography angiography revealed unusual heart‐shaped, intertwined vascular nets, informing the choice of Conbercept for intravitreal injection.
Shangkun Ou   +3 more
wiley   +1 more source

Phosphate in Physiological and Pathological Mineralization: Important yet Often Unheeded

open access: yesMedComm, Volume 6, Issue 7, July 2025.
Phosphate serves as a building block for physiological mineralization, and as a signaling molecule that regulates the activity of mineralizing cells. The disturbance in these processes could induce a series of pathological mineralization, with abnormal mineralization of hard tissues and ectopic mineralization of soft tissues being the most ...
Wen Qin   +8 more
wiley   +1 more source

Progress in Nanotechnology for Treating Ocular Surface Chemical Injuries: Reflecting on Advances in Ophthalmology

open access: yesAdvanced Science, Volume 12, Issue 6, February 10, 2025.
A review of progress in nanotechnology for treating ocular surface chemical injuries. This is the most detailed review on the topic, serving as a microcosm of advancements in the application of nanotechnology in ophthalmology. It analyzes 12 nanocarrier platforms, namely liposomes, nanoemulsions, nanomicelles, nanowafers, nanostructured lipid carriers,
Qiaoran Qi   +8 more
wiley   +1 more source

Topical Povidone Iodine 2.5% Versus 5% for Endophthalmitis Prophylaxis During Intravitreal Injections

open access: yesJournal of Ophthalmology, Volume 2025, Issue 1, 2025.
Purpose Topical povidone iodine (PI) has been shown to reduce the risk of endophthalmitis following intravitreal injections (IVIs). However, PI is a known ocular irritant and can result in significant eye discomfort. Currently, 5% PI is the most used concentration for ocular surface disinfection prior to IVI. 2.5% PI has been proposed as an alternative
Radwan S. Ajlan   +7 more
wiley   +1 more source

Cystoid Macular Edema Secondary to Hyperviscosity Syndrome in Waldenström Macroglobulinemia: A Case Report of Multimodal Treatment Response and the Adjunctive Role of Acetazolamide

open access: yes
The Kaohsiung Journal of Medical Sciences, Volume 41, Issue 12, December 2025.
Yu‐Mei Yang   +3 more
wiley   +1 more source

Endophthalmitis following intravitreal injections administered by junior medical officers in rural Western Australia

open access: yesClinical &Experimental Ophthalmology, Volume 52, Issue 8, Page 853-860, November 2024.
Abstract Background Patients in rural Australia have limited access to intravitreal treatments due to a maldistribution of the ophthalmology workforce. To improve access, a novel outreach service model was implemented whereby junior medical staff administered intravitreal injections under a supervising ophthalmology consultant.
Jackson Chee Chea Lee   +4 more
wiley   +1 more source

Home - About - Disclaimer - Privacy